Johnson Midwest Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Johnson Midwest Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$2K	–	332
2022 Q1	$2K	Hold	500	–	–	﹤0.01%	258
2021 Q4	$2K	Hold	500	–	–	﹤0.01%	274
2021 Q3	$2K	Hold	500	–	–	﹤0.01%	285
2021 Q2	$2K	Hold	500	–	–	﹤0.01%	271
2021 Q1	$2K	Hold	500	–	–	﹤0.01%	252
2020 Q4	$2K	Buy	+500	New	+$1.62K	﹤0.01%	253

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Johnson Midwest Financial's ATRS Position: Q2 2022 in Review

Johnson Midwest Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 500 shares — an estimated $2K sold.

Johnson Midwest Financial first reported a position in ATRS in Q4 2020 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Johnson Midwest Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Johnson Midwest Financial sold 500 Antares Pharma, Inc. shares in Q2 2022, an estimated $2K.
Johnson Midwest Financial first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 6 quarters.
Johnson Midwest Financial's Antares Pharma, Inc. position peaked at $2K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Johnson Midwest Financial's 13F filing for Q2 2022, filed 18 Jul 2022.